The CONMED Corporation is a publicly traded American manufacturer of medical equipment, primarily orthopedic, endoscopy, and general surgical tools. In 2021, orthopedics made up $550 million of its revenue. It is part of the S&P 600. It has manufacturing facilities in the United States and Mexico, and sales and distribution offices internationally.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CNMD | CONMED Corp | 2025-10-30 16:30:05 | 44.49 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNMD | 0000816956 | CONMED Corp | US2074101013 | Z6C0YCECH9DCU5ZIQW84 | 160977505 | NYSE | 3845 | Electromedical & Electrotherapeutic Apparatus | 1231 | DE | 11311 CONCEPT BOULEVARD | LARGO | FL | 33773 | UNITED STATES | US | 727-214-2974 | 11311 CONCEPT BOULEVARD, LARGO, FL, 33773 | 11311 CONCEPT BOULEVARD, LARGO, FL, 33773 | — | — | 1970 | Curt Hartman | 4,100 | https://www.conmed.com | 1,600,000,000 | 31,299,194 | 30,954,963 | The CONMED Corporation is a publicly traded American manufacturer of medical equipment, primarily orthopedic, endoscopy, and general surgical tools. In 2021, orthopedics made up $550 million of its revenue. It is part of the S&P 600. It has manufacturing facilities in the United States and Mexico, and sales and distribution offices internationally. | 2025-10-30 14:20:14 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 1,600,000,000 | -1,500,000,000 | -48.3871 | 30,908,835 | 128,268 | 0.4167 |
| 2023 | 3,100,000,000 | 900,000,000 | 40.9091 | 30,780,567 | 281,128 | 0.9217 |
| 2022 | 2,200,000,000 | -700,000,000 | -24.1379 | 30,499,439 | 1,088,193 | 3.6999 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Patrick J. Beyer | Chief Operating Officer | 2024 | 584,833 | 0 | 699,883 | 398,331 | 517,236 | 4,300,085 |
| Peter Shagory | EVP | 2024 | 368,725 | 0 | 212,551 | 198,230 | 7,112 | 1,424,045 |
| Curt R. Hartman | Chair, Chief Executive Officer, President | 2024 | 966,230 | 0 | 2,657,542 | 882,622 | 202,961 | 7,366,555 |
| Todd W. Garner | Chief Financial Officer, Executive Vice President | 2024 | 565,776 | 0 | 2,099,933 | 397,860 | 79,337 | 4,642,713 |
| Brent Lalomia | Vice President | 2024 | 317,700 | 0 | 212,551 | 175,073 | 49,608 | 1,392,359 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 3,900 |
| 2023 | 4,000 |
| 2022 | 4,100 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1,307,015,000 | 1,244,744,000 | 1,045,472,000 |
| Cost Of Revenue | 573,983,000 | 568,499,000 | 474,227,000 |
| Gross Profit | 733,032,000 | 676,245,000 | 571,245,000 |
| Research And Development Expenses | 54,426,000 | 52,602,000 | 47,152,000 |
| General And Administrative Expenses | 117,463,000 | 503,040,000 | 454,039,000 |
| Operating Expenses | 532,706,000 | 555,642,000 | 501,191,000 |
| Operating Income | 200,326,000 | 120,603,000 | 70,054,000 |
| Net Income | 132,423,000 | 64,459,000 | -80,582,000 |
| Earnings Per Share Basic | 4.29 | 2.1 | -2.68 |
| Earnings Per Share Diluted | 4.25 | 2.04 | -2.68 |
| Weighted Average Shares Outstanding Basic | 30,846,000 | 30,668,000 | 30,040,000 |
| Weighted Average Shares Outstanding Diluted | 31,150,000 | 31,548,000 | 30,040,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 24,459,000 | 24,296,000 | 28,942,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 237,733,000 | 242,279,000 | 191,345,000 |
| Inventories | 346,719,000 | 318,324,000 | 332,320,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 640,007,000 | 615,649,000 | 581,226,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 115,793,000 | 120,722,000 | 115,611,000 |
| Other Assets Non Current | 116,357,000 | 96,111,000 | 93,877,000 |
| Total Assets Non Current | 139,900,000 | 1,684,372,000 | 1,716,366,000 |
| Total Assets | 2,306,247,000 | 2,300,021,000 | 2,297,592,000 |
| Accounts Payable | 102,248,000 | 88,224,000 | 73,393,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 715,000 | 708,000 | 69,746,000 |
| Other Liabilities Current | 109,799,000 | 151,728,000 | 98,680,000 |
| Total Liabilities Current | 278,130,000 | 310,729,000 | 296,552,000 |
| Long Term Debt | 905,066,000 | 973,140,000 | 985,076,000 |
| Other Liabilities Non Current | 86,294,000 | 121,028,000 | 203,694,000 |
| Total Liabilities Non Current | 1,065,436,000 | 1,155,070,000 | 1,255,495,000 |
| Total Liabilities | 1,343,566,000 | 1,465,799,000 | 1,552,047,000 |
| Common Stock | 313,000 | 313,000 | 313,000 |
| Retained Earnings | 560,277,000 | 452,531,000 | 412,631,000 |
| Accumulated Other Comprehensive Income | -58,857,000 | -50,170,000 | -57,858,000 |
| Total Shareholders Equity | 962,681,000 | 834,222,000 | 745,545,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 16,605,000 | 16,200,000 | 16,055,000 |
| Share Based Compensation Expense | 25,558,000 | 24,257,000 | 21,729,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 1,619,000 | 47,068,000 | 5,203,000 |
| Change In Inventories | 31,633,000 | -14,071,000 | 78,564,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 13,910,000 | 21,845,000 | 17,735,000 |
| Change In Accounts Payable | 14,713,000 | 14,849,000 | 13,302,000 |
| Change In Other Liabilities | -4,248,000 | -10,090,000 | -256,000 |
| Cash From Operating Activities | 166,968,000 | 125,348,000 | 33,365,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 13,084,000 | 19,032,000 | 21,785,000 |
| Acquisition Of Business | 0 | 0 | — |
| Other Investing Activities | 0 | 1,000,000 | — |
| Cash From Investing Activities | -13,084,000 | -20,032,000 | -249,529,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 24,677,000 | 24,559,000 | 24,183,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | 0 | 0 |
| Repayment Of Long Term Debt | 753,000,000 | 760,000,000 | 530,000,000 |
| Other Financing Activities | 2,833,000 | 15,937,000 | 8,475,000 |
| Cash From Financing Activities | -151,000,000 | -110,432,000 | 225,000,000 |
| Change In Cash | 163,000 | -4,646,000 | 8,095,000 |
| Cash At End Of Period | 24,459,000 | 24,296,000 | 28,942,000 |
| Income Taxes Paid | 15,221,000 | 19,879,000 | 9,074,000 |
| Interest Paid | 32,654,000 | 33,687,000 | 26,081,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 4.29 | 2.1 | -2.68 |
| Price To Earnings Ratio | 15.9534 | 52.1476 | -33.0746 |
| Earnings Growth Rate | 104.2857 | -178.3582 | -225.2336 |
| Price Earnings To Growth Ratio | 0.153 | -0.2924 | 0.1468 |
| Book Value Per Share | 31.2093 | 27.2017 | 24.8184 |
| Price To Book Ratio | 2.1929 | 4.0259 | 3.5715 |
| Ebitda | 201,546,000 | 140,313,000 | -26,548,000 |
| Enterprise Value | 2,992,422,240 | 4,308,004,680 | 3,688,625,600 |
| Dividend Yield | 0.0117 | 0.0073 | 0.0091 |
| Dividend Payout Ratio | 0.1863 | 0.381 | -0.3001 |
| Debt To Equity Ratio | 0.9409 | 1.1674 | 1.4148 |
| Capital Expenditures | 11,676,000 | 21,311,000 | 22,803,000 |
| Free Cash Flow | 155,292,000 | 104,037,000 | 10,562,000 |
| Return On Equity | 0.1376 | 0.0773 | -0.1081 |
| One Year Beta | 0.5051 | 1.373 | 1.2468 |
| Three Year Beta | 1.1361 | 1.242 | 1.355 |
| Five Year Beta | 1.2935 | 1.3096 | 1.2431 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Farkas Charles | Director | 2025-09-12 | 1,103 | D | 15,756 |
| Farkas Charles | Director | 2025-09-12 | 897 | D | 14,859 |
| Kelderman Kim | Director | 2025-09-08 | 500 | A | 500 |
| Kelderman Kim | Director | 2025-09-08 | 6,227 | A | 6,227 |
| Garner Todd W | Executive Vice President & CFO | 2025-08-07 | 598 | D | 0 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Nicholas Van Taylor | 2019-03-14 | TX03 | Purchase | 2019-02-15 | Spouse | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 2025-09-30 | 938,719 | 19,960 | 47.03 |
| Parkside Financial Bank & Trust | 2025-09-30 | 848 | 18 | 47.1111 |
| STRS OHIO | 2025-09-30 | 4,703 | 100 | 47.03 |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS LLC | 2025-09-30 | 1,305,741 | 27,764 | 47.03 |
| Covestor Ltd | 2025-09-30 | 8,000 | 179 | 44.6927 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| SHELTON FUNDS | 2025-08-31 | K Shares | SMLKX | 1,202 | 65,340.72 | 0.1264 |
| SHELTON FUNDS | 2025-08-31 | Investor Shares | SMCIX | 1,202 | 65,340.72 | 0.1264 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Multi-Asset Real Return Fund - Class A | SEIAX | 440 | 23,918.4 | 0.0032 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Extended Market Index Fund - Class A | SMXAX | 5,408 | 293,978.88 | 0.0243 |
| VALIC Co I | 2025-08-31 | Small Cap Special Values Fund | VSSVX | 8,876 | 482,499.36 | 0.2629 |